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ABSTRACT
Aim: Metabolite concentrations by in vivo magnetic resonance spectroscopy and ex 
vivo NMR spectroscopy were compared with excised normal human tissue relaxation 
times and tissue homogenate contents.
Hypothesis: Biochemical  analysis  combined  with  NMR  and  MR  spectroscopy 
defines better tissue analysis.
Materials and Methods: Metabolites were measured using peak area, amplitude and 
molecular weights of metabolites in the reference solutions. In normal brain and heart 
autopsy, muscle and liver biopsy tissue ex vivo NMR peaks and spin-lattice (T1) and 
spin-spin  (T2)  relaxation  times,  were  compared  with  diseased  tissue  NMR  data  in 
meningioma brain,  myocardial  infarct  heart,  duchene-muscular-dystrophy  muscle  and 
diffused-liver-injury liver  after  respective in vivo proton MR spectroscopy was done. 
NMR  data  was  compared  with  tissue  homogenate  contents  and  serum  levels  of 
biochemical parameters.
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Results: The quantitation of smaller NMR visible metabolites was feasible for both 
ex  vivo  NMR and in  vivo  MR spectroscopy.  Ex  vivo  H-1  NMR and in  vivo  MRS 
metabolite characteristic peaks (disease/normal data represented as fold change), T1 and 
T2, and metabolites in tissue homogenate and serum indicated muscle fibrosis in DMD, 
cardiac  energy  depletion in  MI heart,  neuronal  dysfunction in  meningioma brain  and 
carbohydrate-lipid metabolic crisis in DLI liver tissues.
Conclusion: This preliminary report highlights the biochemical-magnetic resonance 
correlation as basis of magnetic resonance spectroscopic imaging data interpretation of 
disease.
Key  words: MRS  Magnetic  Resonance  Spectroscopy,  NMR  Nuclear  Magnetic  Resonance,  DMD 
Duchene Muscular Dystrophy, MI Myocardial Infarction, DLI Diffused liver Injury
INTRODUCTION
Nuclear Magnetic Resonance (NMR) techniques are now extensively utilized for imaging 
and spectroscopy of diseased organs in the human body (1, 2). After initial success of in vivo 
NMR metabolite quantification,  attempts were made to detect NMR peaks and resonance 
assignments and ways of correlating the in vivo MR spectroscopy peaks with biochemical 
reactions in the disease to make clinical decisions. Enormous efforts have been made in last 
decade in the direction of high-field clinical magnets, fast 3D localization schemes and robust 
software for in vivo MR spectroscopy and ex vivo NMR studies aimed at measuring in vivo 
metabolite concentrations in tissues. In recent past, non-invasive NMR and in vivo metabolic 
characterization  has  attracted  considerable  attention  of  chemical  NMR  spectral 
characterization  in  clinical  radiology.  The  potential  of  this  non-invasive  technique  in 
providing detailed metabolite concentrations and metabolic screening in selective image area 
have not  been fully explored.  The reason of doubt on the complete success of this  non-
invasive tool is now realized due to insufficient information on the relaxation values, MR-
visibility and reliable quantitation of metabolites by NMR and MRS methods. However, these 
clinical methods are in infancy and limited to research studies promising it  of high value 
[1,2,3,4]. Both of them suffer from several factors such as spatial resolution, chemical shift 
resolution and peak assignments and their peak standardization is not yet resolved despite of 
several  methods applied [4,5]. The potentials  of  this  non-invasive technique in  providing 
detailed metabolite concentrations and metabolic screening in selective image area have not 
been fully explored due to lack of sufficient information on the MR-visibility of metabolites 
by NMR and MRS methods. Quantification of these metabolites suffers from several factors 
and method is not yet resolved. Main reasons for this discrepancy are incomplete information 
on the in vivo dynamic patho-chemical changes in tissues and their  effects on NMR and 
physical parameters of diseased tissues [6]. The obvious reason of it is complexity of in vivo 
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
NMR signal as outcome of physical, chemical and biological processes at the molecular level. 
It  makes  difficult  the  interpretation  of  observed  NMR  signal  and  its  correlation  with 
metabolic component in the tissue. Still, ideal most approaches of in vivo MR spectroscopy 
and  correlative  biochemical  analysis  of  disease  (metabolic  screening)  to  make  accurate, 
specific clinical decision are far from clinical acceptability. However, it indicated that in vitro 
NMR information of tissue can be extrapolated to  in vivo tissue processes [7, 8]. Various 
NMR in vitro and in vivo spectroscopy techniques can predict both qualitative and relative 
quantitative information on biochemical contents in tissues. The possibility of non-invasive 
clinical MR spectroscopy measurements opened new vistas for  NMR methods to become 
diagnostic  tool  [7,  8,  9].  Moreover,  there  is  paucity  of  information  in  literature  on 
identification and quantification of MR ‘visible’ metabolite peaks by in vitro and in vivo H-1 
NMR spectroscopy of normal and diseased tissues like normal liver, muscle, heart and brain. 
The  present  study, we  focused  on  measurements  of  T1  and  T2  relaxation  values, 
identification and quantitation of metabolites by ex vivo NMR resonances and comparison 
with  in  vivo  MR visible  peaks  and  tissue  homogenate  contents  as  NMR specific  tissue 
characteristics. It is a preliminary attempt also to analyze in vivo MR visible metabolites and 
compare  them  with  a  priori  knowledge based  high  resolution  ex  vivo NMR  visible 
metabolites  in  perchloric  acid  tissue  extracts.  For  it,  model  metabolite  solutions  were 
analyzed  for  their  high  resolution  in  vitro NMR chemical  shift  peak  positions.  Duchene 
Muscular Dystrophy (DMD) muscle and diffused liver injury(DLI) liver (right lobe) biopsies 
and  meningioma  (MB)  brain  (cerebrum),  myocardial  infarction(MI)  heart(left  ventricle) 
autopsy tissues extracts were compared with tissue extracts from normal tissues for T1, T2 
relaxation constants and tissue biochemical contents in patient sera. The comparison of serum 
biomarkers  and  tissue  contents  with  tissue  MR  information  may  be  useful  to  interpret 
laboratory  data  and  in  vivo/ex  vivo MR  data  correlation.  Taking  together  NMR  visible 
metabolites  and  tissue  homogenate  contents  along  with  altered  serum  clinical  chemistry 
values it is possible to predict better biochemical definition of the organ specific diseases.
MATERIALS AND METHODS
The  excised  tissue  longitudinal  (T1)  and  transverse  (T2)  relaxation  constants  were 
measured using Bruker Biospec NMR spectrometer at 90 MHz magnetic field by inversion 
recovery and Carr-Purcell McGill (CPMG) methods respectively [9].
For  in vivo MRS localized and  ex vivo  H-1 NMR spectroscopy,  patients with proven 
history  of  Duchene  Muscular  Dystrophy  (DMD),  myocardial  infarction(MI), 
meningioma(BM) and diffused-liver-injury  (DLI),  were  recruited  to  get  liver  and muscle 
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biopsies  and  heart  and  brain  autopsies  as  recommended  by  institutional  human  research 
ethical committee at institute hospital. The selection of patients and specimen collection was 
in  compliance  with  purpose  to  include  documented  acute  episode  of  these  diseases  and 
minimal injury during study. For other tissue experiments of ex vivo NMR and tissue content 
analysis,  Duchene  Muscular  Dystrophy  (DMD)  muscle  and  diffused  liver  injury(DLI) 
liver(right lobe) biopsies and meningioma(MB) brain(cerebrum), myocardial infarction(MI) 
heart(left  ventricle)  autopsies were obtained as by-products  from operation theatre.  These 
tissues were frozen in liquid N2 and each tissue was used for tissue homogenate preparation 
by sonication process at 4°C for 3 minutes for liver and brain, and 20 minutes for muscle and 
heart  specimens.  These  homogenates  were  used  for  measurement  of  lipids,  pyruvate  and 
lactate and patient sera were used for enzymes alkaline phosphatase, SGPT, SGOT, creatine 
kinase, pyruvate and lactate assay on clinical chemistry analyzer  [10].  Simultaneously,  in  
vivo MRS and in vitro NMR biopsy spectra peaks were identified and compared to measure 
the metabolite concentrations.
In Vivo MR Spectroscopy
For  in  vivo MRS localized  spectroscopy  of  DMD and  MB patients  were  positioned 
supine under surface coil covering reference location by its axial and sagittal beams. The area 
of interest was positioned in axial plane to place it close with magnet isocenter. Shimming 
coils focused on water signal to selected area at carrier frequency.
For DMD, gastronemius muscle, spectra were recorded and metabolites were measured 
on a 1.5 Tesla MR unit with a H-1 double surface coil having an 8 inch transmitter and 3 inch 
receiver coil [11]. Selective water suppressed H-1 spectra were taken with 1331 pulse-depth 
resolved surface coil spectroscopy program at following setting: spectral width 650 MHz, TR 
= 3000 ms, TE = 25 ms, data points = 1024; inter pulse variation =2.5 – 3.0 ms [12]. Base 
line correction, resolution enhancement, manual FT-spectral phasing were made. The 1331-
pulse  sequence  caused  180° phase  shift  between  aliphatic  and  aromatic  spectral  regions 
(aliphatic peaks up and aromatic peaks inverted). Water suppression H-1 spectral chemical 
shifts were referenced to the position of water at 4.86 ppm [12, 13].  The metabolite peaks 
assignment and concentrations were measured by using NMR 1 and Peakfit software (SPSS, 
Korea).
For in vivo MRS localized spectroscopy of heart, patients were positioned under surface 
coil  by  sagittal  beams.  The  resolution  enhancement  was  made  by  multiplying  FID  free 
induction decay with sine function before Fourier transform and exponential filtering. Hahn 
spin echo pulse sequence was used to eliminate short  T2 protons of cell by 60 ms delay 
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
between 90 degree and 180 degree pulses. Scan settings were similar as above in muscle in 
vivo MRS [12, 13].
For  in vivo  MR localized spectroscopic studies were done on 5 patients suffered from 
meningioma. 1.5 Tesla MR unit was using head coil with circularly polarized B1 field using 3 
slice selective 90° RF pulses creating stimulated echo, was used. Echoes from protons of 3 
slices belonging to selective volumes were thus obtained. The interval of second and third 
slice selective RF pulse was kept 30 ms constantly with suitable variations of T1 and T2 
weighting. Stimulated echo were obtained at completely relaxed water signal reference with 
following setting: data points = 4096; TR = 1000 ms; TE = 62 ms; spectral width = 4 Hz with 
base line correction, resolution enhancement, manual FT spectral phasing by phase correction 
with  constant  phase  angle.  The  signal  stemming  from  metabolites  was  obtained  by  the 
preceding sequence by three  90° chemical  shifts  selective  pulses at  Larmor  frequency of 
water with bandwidth = 60 Hz. Water relaxed signal was taken as internal standard. Chemical 
shifts were referenced to the position of water  (4.78 ppm) [2,  3, 4]. Proton resonances of 
spectra were assigned on the basis of standard assignments. Biochemical assays for lactate, 
pyruvate and acetoacetate were measured in homogenates and SGOT, lactate and pyruvate in 
sera by Boeringer Manheim kit methods [10].
For in vivo MRS of liver, patients were positioned under surface coil covering reference 
location by its axial and sagittal beams. Selective water suppressed 1H spectra were taken 
with  1331  pulse  depth  resolved  surface  coil  spectroscopy  program  with  scan  setting  at 
spectral  width  =  650  MHz,  TR=  3000  ms,  TE=  25  ms,  data  points=1024,  inter  pulse 
variation= 2.5 and 3.0 ms [15].  The 1331 pulse sequence caused 180 degree  phase shift 
between aliphatic upside with chemical shift change 0.1 ppm and aromatic inverted spectra 
peaks.
Ex Vivo NMR Spectroscopy
For ex vivo NMR experiments, powder was prepared by 70 % perchloric acid treatment 
(0.1 ml/ml of tissue perfusate). The muscle was inserted into an NMR tube and minimum 
amount of isotonic D2O in Ringer solution was added for NMR locking. For calibration, a 
capillary containing 10 % tetramethylsilane in CDCl3 was inserted as external reference. H-1 
NMR spectroscopy using selective water saturation technique was carried out on JEOL-400 
FX  PFT-400  MHz instrument  located  at  central  NMR facility  [9].  Chemical  shifts  were 
referenced relative to =N.CH3 of creatine assigned as  δ=3.0(TSP in D20 at 0.0 ppm). Hahn 
spin echo pulse sequence used to eliminate short T2 protons of cell, by 60 ms delay between 
90° and 180° pulses. The field frequency was controlled by locking the deuterium signal of 
the H2O solution added in the sample while the sample tube was spun at room temperature of 
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30°C. For selective water saturated NMR signals in the muscle sample, NMR probe circuit 
was modified to perform homonuclear gated proton decoupling. A time interval of 5 seconds 
was taken between the end of accumulation at each free induction decay and next analytical 
pulse. During this time interval, the water frequency was irradiated with sufficient power to 
saturate  the signals  of water  proton.  The irradiated  power  by tuning power  amplification 
degrees of NMR transmitter was used and the value of 30 dB corresponded to several mG. H-
1 NMR spectra were obtained by accumulation of 100 scans with Fourier transforms being 
performed  every  10  scans  of  free  induction  decay  obtained  by  a  90° pulse.  The  high 
resolution  spectral  portion  was  obtained  by  subtracting  broad  component  from  original 
spectra. Some spectra were measured by high resolution NMR spectroscopy where 90° -τ -90
°-  τ,  1331  water  suppression  pulse  sequences  were  used  for  D2O extracts  by  one  pulse 
sequence with pulse angle 90°, recycling time 1.7 seconds. Chemical shifts were referenced 
relative to =N.CH3 of creatine assigned as δ = 3.0 (referenced against to external TSP in D2O 
at 0.0 ppm. Biochemical serum analysis for creatine kinase and SGPT was done by routine 
autoanalyzer methods [10].
Myocardial infarction heart autopsy samples were obtained from autopsy room. 50 grams 
pieces from ventricular  heart  were quickly frozen after  they were perfused at 37  °C with 
oxygenated (90 % O2 with 5 % CO2) carbogen gas in Kreb’s Hanseleit buffer (pH 7.4) as 
previously explained. The heart perchloric extracts were prepared as previously explained. 
Freeze dried powder dissolved in 99 % D2O which was obtained by 70 % perchloric acid 
treatment (0.1 ml/ml tissue perfusate) and centrifugation at 2000 x g for 15 minutes at 4°C. 
The samples in D2O were used for NMR mesasured [9]. Water presaturation pulse sequences 
were used for D2O extracts followed by 90°-τ-180°-τ Hahn spin echo NMR pulse sequence. 
Multiplying FID with sine function before Fourier transform and exponential filtering made 
resolution  enhancement.  Chemical  shifts  were  recorded  with  reference  to  TSP  added  to 
extracts. Hahn spin echo pulse sequence used to eliminate short T2 protons of cell, by 60 ms 
delay between 90° and 180° pulses(1). H-1 in vitro NMR and in vivo MRS were done using 
procedures similar to those for muscle studies. Biochemical estimations for creatine kinase-
MB, cholesterol, triglycerides, SGOT and lactate made using standard procedure [10].
Brain autopsy samples were used for  in  vitro  NMR spectroscopy.  Brain tissues were 
immediately cooled in liquid nitrogen gas at 15 seconds and homogenized at 4 °C in Kreb’s 
Henseleit buffer(pH 7.4) in D2O using Potter Elvehjem homogenizer with teflon pestle and 
sonicated to 20 seconds at 3 °C to improve homogeneity. In vitro NMR spectra were recorded 
at 37  °C on pulsed Fourier transform mode using 180°-τ-90° inversion recovery spin echo 
IRSE pulse sequence with inter scan delay of 1 second, τ = 0.6 seconds, TR = 2 seconds, data 
points  = 8192,  spectral  width = 500 Hz. Resolution peaks were  enhanced with Gaussian 
multiplication. Tetramethylsilane (TMS) was used as 0.0 ppm reference and was placed in 
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
capillary within the NMR tube. Hahn spin echo pulse sequence used to eliminate short T2 
protons of cell, by 60 ms delay between 90° and 180° pulses [12].
Nine patients suffering from diffused liver injury were clinically investigated with need 
of  ex vivo NMR spectroscopy information.  Liver  biopsy obtained from surgical  operation 
theatre  and  extracts  were  prepared  in  the  same  manner  as  muscle  biopsy  samples  were 
processed for  in vitro NMR spectroscopy. The  in vitro NMR measurement was made with 
selective water saturation technique. Selective spin echo sequence consisting 90° –180° at 
delay time 60 ms, 4096 data points, spectral bandwidth = 350 Hz against water reference at 
4.76 ppm at 30 °C. Measurements were made using selective selection water suppressed H-1 
spectra in Fourier transform mode using 180°-τ-90° inversion recovery spin echo IRSE pulse 
sequence  [16].  Base  line  correlation,  resolution  enhancement,  manual  Fourier  transform 
spectral phasing was done manually. This pulse sequence caused a 180° pulse shift between 
aliphatic and aromatic spectral regions (aliphatic peaks up and aromatic peaks inverted). All 
were phased up with chemical shift change 0.1 ppm [10].
For quantification of metabolites, concentration of metabolites was measured by robust 
automated quantification based upon formula:
MW(x).(peak area).(peak amplitude(x)).peak width(x)
Conc(x) = conc(X)--------------------------------------------------------------------- 
MW(X).(peak area).(peak amplitude(X)).peak width(X)
where x is metabolite to be measured, X is reference metabolite and MW refers to molecular 
weight. Standard peak assignments and peak area measured the concentration of creatine, 
aspartate, choline, glutamate and other reference solutions.
The standard reference solutions were used for distinct NMR resonance assignments (see 
Figure 1 and Appendix 1) for following peaks:
NAA: A large singlet arises from three protons in methyl group. The resonances of three 
protons of –CH2 group and single proton of CH group are NMR visible as 12 resonances in 
this ABX spin system in the molecule.
Alanine: A quartet at 1.45 ppm and doublet at 3.8 ppm origeinate from CH and CH3 
groups in NMR while single peak at 1.45 ppm in MR spectrum.
Choline: A very large resonance at 3.2 ppm due to 9 equivalent protons of three CH3 
groups and tiny several resonances of two CH2 groups are NMR visible in choline molecule.
Myo-inositol: Six CH group protons of inositol ring show up a large singlet at 3.6 ppm 
and two resonances at 3.56 (C3 protons) and 4.06 ppm (C2 proton) by NMR spectrum while 
MR spectrum shows only one singlet at 3.6 ppm.
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Glutamate and Glutamine: In NMR spectrum, glutamate symmetric molecule CH group 
and glutamine NH2 groups both show up as triplet peak at 3.75 ppm and complex multiplet 
tetrad peak from two CH2 groups (4 protons) at 2.1 to 2.4 ppm in NMR spectrum.
Creatine: In NMR spectrum, creatine -CH2- protons showed strong peak at 3.0 ppm and 
two other smaller peaks.
GABA: Three CH2 groups show up at three different peaks including 2.95 ppm as triplet, 
second triplet at 2.2 ppm and a quintet at 1.95 ppm as a result interactions between three CH2 
groups as visible NMR peaks while MR spectrum shows only singlets at 1.9 and 2.2 ppm.
Figure 1. Ex vivo standard H-1 500 MHz NMR spectra of reference metabolites (creatine, choline, 
glutamine/glutamate, lactate, NAA, GABA, myo-inositol are shown with their peaks used to match 
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
resonance assignments by ex vivo NMR and in vivo MR spectroscopy of tissues. For calculation of 
relaxation time, peak height at half width (FWHM) is shown on at top on right. The lower two rows show 
the high resolution NMR spectroscopy spectral assignments of molecules with their protons and 
structures.
For quantitation of metabolites we used micrometer method to measure peak area and 
comparison with peak area of reference solutions of known concentrations as shown in Figure 
1. For relaxation times (T1 and T2) measurements of different normal and diseased tissues, 
15  mm3 tissue  cubes  were  placed  in  505  Wilmad NMR tube  bottom and  T1  (inversion 
recovery  pulse  sequence),  T2  (CPMG  pulse  sequence)  were  measured  with  usable  echo 
obtained every 10 ms [17].
RESULTS 
Ex vivo H-1 NMR and in vivo MRS metabolite peaks, T1 and T2, tissue homogenate 
contents and serum metabolites in normal human tissues were compared with DMD muscle, 
MI heart,  meningioma brain and DLI liver tissues (disease/normal data represented as fold 
change). The comparison of clinically relevant relaxation times T1 and T2, NMR/MRS, tissue 
contents and serum chemistry data are shown in different tissues as Tables 1-4. 
Ex vivo NMR peaks (Figure 2) and in vivo MRS peaks (Figure 3) in different tissues are 
shown as  curve-fitted  spectra  for  peak-area  measurement  by  NMR-1  program.  For  peak 
identification, different peaks were labeled to distinguish peaks in diseased tissues. Different 
spectral peaks were compared by NMR and MRS methods. Calculation method of metabolite 
concentrations  by NMR and MRS methods was  field  independent.  However,  normal  and 
diseased tissues showed distinct relaxation times. 
Ex vivo H-1 NMR spectra of DMD muscle exhibited (see Figure 2 A) decreased lactate 
(18 fold), increased glutamine(1.5 fold); in vivo H-1 MRS peaks evidenced (see Figure 3 A) 
increased  PCr  (2-6  fold),  fatty  acids(12  fold)  as  a  result  of  muscle  fibrosis  (Table  5). 
Furthermore,  elongated  relaxation  times  T1  (1.6  fold),  T2  (1.3  fold);  DMD  muscle 
homogenate decreased phospholipids (0.49 fold), triglycerides (0.9 fold) levels and elevated 
serum SGPT (5 fold) and creatine kinase (2.6 fold) were observed.
Ex vivo H-1 NMR spectra of MI heart evidenced (see Figure 2 B) increased cholesterol 
(51.5 fold), taurine (2.8 fold), creatine (32.3 fold) with decreased PCr/Cr (0.54 fold); in vivo 
H-1 NMR peaks evidenced (see Figure 3 B) increased cholesterol (2.27 fold) and PCr/Cr (1.6 
fold), T2 (1.16 fold), increased cholesterol (1.5 fold), lactate (1.5 fold) shown in Table 6. MI 
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heart autopsy homogenates showed elevated lactate (1.52 fold) and cholesterol (1.46 fold), 
elevated serum SGOT(6 fold), CK-MB(3.24 fold) and lactate(2.4 fold) were observed.
Ex vivo H-1 NMR spectra of meningioma brain evidenced (see Figure 4 A) increased 
lactate (1.32 fold), alanine (2.7 fold), creatine (2.1 fold) and decreased acetate (0.5 fold); in 
vivo H-1 NMR spectra evidenced (see Figure 4 B) increased aspartate (15.3 fold), decreased 
PCr/Cr (0.28 fold) as a result of displacement of neuronal cells by meningioma and energy 
depletion  (Table  7).  Further,  elongated  relaxation  times  T1(1.1  fold),  T2  (1.6  fold); 
meningioma  brain  homogenate  increased  lactate(1.7  fold),  decreased  pyruvate(0.87  fold), 
acetoacetate (0.56 fold) levels and serum elevated levels of lactate(3.5 fold), SGOT(2.77 fold) 
and decreased pyruvate(0.83 fold) were observed.
Ex vivo H-1 NMR spectra of diffused liver injury effected liver (see Figure 5 A) showed 
increased PCr/Cr(2.2 fold), phosphorylcholine (8.5 fold), taurine (4 fold); in vivo H-1
NMR spectra evidenced (see Figure 5 B) decreased aspartate (0.43 fold), as a result of 
lipid and carbohydrate metabolic crisis (Table 8). Furthermore, elongated relaxation times T1 
(2.09  fold),  T2  (1.6  fold);  DLI  liver  homogenates  increased  phospholipids  (1.5  fold), 
triglyceride (1.5 fold) levels and serum elevated of SGPT (7.6 fold), alkaline phosphatase (6 
fold) and bilirubin (2.8 fold) were observed.
Table 1. Comparative NMR-biochemical correlation analysis of muscle by different 
methods (n=7)
Method Normal muscle Duchene Muscular Dystrophy muscle
In vitro pulsed NMR
T1
T2
600+20 ms
65+9 ms
1049+86 ms
98+4 ms
In vitro NMR spectroscopy
Lactate
Glutamate
37.6 mM
11.8 mM
2.3 mM
19.5 mM
In vivo NMR spectroscopy
Phospholipids
Fatty acids
26 mM
29 mM
106 mM
347 mM
Biochemical tissue metabolite 
contents(n=6)
Phospholipids
Triglycerides
139.7+12.4 mg %
30.2+8.1 mg%
68.8+8.3 mg%
26.7+5.9 mg%
Biochemical serum levels* 
(n=7)
Creatine kinase 21.1+2.9 IU 55+2.4 IU
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
SGPT 13.6+1.4 IU 69+10 IU
*IU is defined as µ moles substrate used per minute per mg enzyme protein.
Table 2. Comparative NMR-biochemical correlation analysis of old myocardial 
infracted-hypertensive heart by different methods (n=7)
Method Normal heart autopsy MI-hypertensive autopsy
In vitro pulsed NMR
T1 ms
T2 ms
946+30 ms
68+9 ms
1126+46 ms
79+12 ms
In vitro NMR spectroscopy
Cholesterol
Phosphocreatine*/creatine
Taurine(total)
Creatine 
0.74 mM
18*+6.1 mM
67.2*+16.8 mM
0.20 mM
38.1 mM
6.3+6.3 mM
187.5*+51.9 mM
6.46 mM
In vivo NMR spectroscopy
Cholesterol
Phosphocreatine/creatine 
13.5 mM
24.0 mM
30.7 mM
38.1 mM
Biochemical tissue metabolite 
contents (n=6)
Triglycerides
Cholesterol
Lactate 
106+8.1 mg%
175+5.8 mg%
89.4+4.8 µg% 
110+9.6 mg%
256+21.3 mg%
136.6+2.9 µg%
Biochemical serum levels** (n=7)
SGOT
CK-MB
Lactate 
23.4+2.9 IU
19.5+2.4 IU
24.8+7.9 µg%
142.5+34.5 IU
63.2+3.1 IU
69.2+16.5 µg%
*Phosphocreatine peak areas were used to calculate concentration.
**IU is defined as µ moles substrate used per minute per mg enzyme protein.
Table 3. Comparative NMR-biochemical correlation analysis brain with meningioma by 
different methods
Method Normal brain Meningioma
In vitro pulsed NMR:
T1
T2
774+23 ms
145+81 ms
849+15.2 ms
234+16 ms
In vitro NMR spectroscopy
Lactate
Alanine
14.4 mM
0.79 mM
19 mM
2.16 mM
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Acetate
Creatine 
0.22 mM
2.61 mM
0.11 mM
5.5 mM
In vivo NMR spectroscopy
N-acetyl aspartate
Glutamine/glutamine
Aspartate
Phosphocreatine/creatine
18 mM
7.2 mM
2.3 mM
72.3 mM
-
-
35.3 mM
20.0 mM
Biochemical tissue metabolites (n=5)
Lactate
Pyruvate
Acetoacetate 
146.6+8.8 µg%
98.8+3.5 µg%
36.6+2.1 µg%
249+4.8 µg%
86.2+4.9 µg%
20.5+1.8 µg% 
Biochemical serum levels* (n=5)
Lactate
Pyruvate
SGOT
24.8 µg%
95.6 µg%
23.4 IU 
85.5 µg%
79.8 µg%
64.8 µg%
*IU is defined as µ moles substrate used per minute per mg enzyme protein.
Table 4. Comparative NMR-biochemical correlation analysis of liver with diffused 
injury by different methods
Method Normal liver Diffused liver injury
In vitro pulsed NMR
T1 ms
T2 ms
448+20 ms
88+7 ms
939+11 ms
144+9 ms
In vitro NMR spectroscopy
Phosphocreatine/creatine
Phosphorylcholine
Taurine
0.48 mM
7.2 mM
5.75 mM
1.06 mM
61.3 mM
23 mM
In vivo NMR spectroscopy
Glutamine
Aspartate
36.1 mM
6.27 mM
35.2 mM
2.7 mM
Biochemical tissue metabolites
Phospholipids
Triglycerides
113.8+3.9 mg%
89.7+4.8 mg%
168.9+5.6 mg%
139.9+3.6 mg%
Biochemical serum levels*
SGPT
Alkaline phosphatase
Bilirubin
18.5+1.9 IU
39.5+7.8 IU
1.5+0.2 mg%
140.9+15.4 IU
239.9+23.4 IU
4.2+0.6 mg%
*IU is defined as µ moles substrate used per minute per mg enzyme protein.
Table 5. I. Resonance assignment and quantification of lactate, glutamine, alanine 
metabolites in normal muscle (a); and Duchene muscular dystrophy (DMD) muscle (b) 
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in perchloric acid extracts by ex vivo H-1 NMR inversion recovery spectra as shown in 
Figure 1A. The NMR reference metabolite standard was 60 mM choline solution for 
metabolite concentration measurement
Chemical 
shifts
(ppm)
assignment Peak area*(mm2)
Normal muscle (a)
Concentration(mM)
DMD muscle (b)
1.5 -(CH2)n phospholipids 26(18.2) 106(51.5)
1.83 =CH(CH2)-(linoleic acid) 6(6.5) 64(36.8)
2.11 =CH(CH2)-(linolenic acid) 1(1.32) 62(21.6)
2.19 =CH(CH2)-(Arachidonic acid) 9(4.62) 80(24.6)
2.42 =CH(CH2)2-(Arachidonic acid) 8 65
5.34 -CH=CH- of 3 18
5.4 Linolenic and 2 21
5.7 Arachidonic acids) - 26
5.95 - 11
6.38 - 18
*signifies peak assignments with clinical significance.
II. Quantification of fat metabolites in normal (a) and Duchene muscular dystrophy (DMD) 
muscle (b) by in vivo MR spectroscopy peaks shown in Figure 2A. The NMR reference 
standard was 40 mM glutamate solution for metabolite concentration measurement
Chemical 
shift
(ppm)
Resonance 
assignment
Peak 
area 
(mm2)
Concentration
(mM)
Normal (a) DMD (b) Normal (a) DMD (b)
1.3 -CH3 lactate 28 19 37.6 2.3
4.1 -CHOH lactate 2 2 - -
2.12
2.43
7.6
C H 2 glutamine
C H 2
-NH2
15
2
1
26
2
1
11.8
-
-
19.5
-
-
1.45
3.75
-CH3 alanine
C H
10
6
11
6
-
-
-
-
2.65
7.0
N+-CH2 carnosine
C-4 (His)
5
3
3
4
-
- 
-
- 
*Peak area is shown as square millimeters.
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Table 6.I. Quantification of lactate, cholesterol, creatine, taurine in normal(a) and 
myocardial infarction heart autopsy(b) perchloric acid extracts by ex vivo H-1 NMR 
spectra shown in Figure 2B. The standard creatine 18 mM solution as reference 
metabolite was used to measure concentration
Chemical 
shift
(ppm)
Assignment 
group
Peak 
area 
(mm2)
Concentration 
(mM)
Normal Myocardial 
infarction 
Normal Myocardial 
infarction 
3.95 -NCH2(-PCr) 13 25* 18 63
3.91 -NCH2(Cr) 11 24 6.1 6.3
3.4 -N+CH2(taurine) 8 14 16.8 51.9
3.25 -N+CH3(carnitine) 5 17* 0.20 6.46
3.2 -SCH2(taurine) 13 34* 67.2 187.5
3.0 -N+CH3(PCr+Cr) 17 35*
2.6 -CH2-(succinate) 3 1
2.45 - C H 2-(glutamine) 1 1
2.12 C H 2-(glutamine) 1 1
1.8 Cholesterol 6 3* 0.74 0.10
1.45 -CH3(alanine) 2 4
1.33 -CH3(lactate) 19 3
*signifies peak assignments with clinical significance.
II. Quantification of metabolites in normal heart (a) and myocardial infarction heart (b) 
by in vivo H-1 MR spectroscopy is shown in Figure 3B. The standard creatine 18 mM 
solution as reference metabolite was used to measure concentration
Chemical 
shift (ppm)
Assignment group Peak area 
(mm2)
Concen
-
tration 
(mM)
Normal Myocardial 
infarction 
Normal Myocardial 
infarction 
1.61 -CH2-CH2 (fatty acids) 10 24
1.83 -CH3 acetate(cholesterol) 30(11 mm) 35(34 mm) 13.5 30.7*
2.03 and 2.4 C H 2(glutamate) 31 26
2.21 C H 2(glutamate) 28 27
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2.63 =N+CH2( a lanine) 20 23
3.02 =NCH(PCr/Cr) 92 117 24 38.1
3.46 -SCH2and=N+CH2(taurine) 57 47
6.11and6.31 Ribose H+(ATP) 16 15
6.31
6.5
6.52
6.78 C2H(tyrosine)
6.8 C6H(tyrosine)
5.5-5.9 -CH=CH-(unsaturated fatty 
acids)
25 28
*shows significant peaks with clinical significance.
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
Figure 2. Ex vivo H-1 NMR spectra of normal tissue (a) and diseased tissue (b) are shown for perchloric 
acid extracts of duchene muscular dystrophy muscle biopsy (Panel A), myocardial infarction heart(Panel 
B), meningioma brain autopsy(Panel C) and diffused liver injury liver biopsy(Panel D). Spin echo 120 ms 
against water 4.76 ppm was used. Metabolites were identified as peaks shown in: Panel A: lactate (2,14), 
glutamate/glutamine (4-6), alanine (3,13), carnosine (7) Panel B: carnosine (7), PCho+glyceroCho (8), 
taurine (9), PCr/Cr (10), lactate (11), urea (12) Panel C: lactate (1), alanine (2), acetate (3), creatine (4,10) 
Panel D: cholesterol and fatty acids (1,2,3), lactate (4), alanine (5), glutamine (6), carnosine (7), 
PCho/glyceroPCho (8), taurine (9), PCr/Cr (10) by selective spin echo pulse sequence.
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Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
Figure 3. In vivo H-1 MR spectroscopy of normal tissue (a) and diseased tissue (b) are shown for 
perchloric acid extracts of duchene muscular dystrophy muscle biopsy (Panel A), myocardial infarction 
heart (Panel B), meningioma brain autopsy (Panel C) and diffused liver injury liver biopsy (Panel D). 
Localized water suppressed 1331 SPECSUP sequence against water 4.76 ppm as reference remnant peak.
Table 7. I. Quantification of metabolites in normal brain autopsy sample (a) and 
meningioma brain autopsy perchloric acid extract (b) by ex vivo H-1 NMR spectra as 
shown in Figure 2C. The standard glutamate 40 mM solution as reference metabolite 
was used to measure concentration
Peak 
#
Chemical 
group
metabolite Chemical 
shift(ppm
)
Peak area
(mm2)
Concen-
tration
(mM)
Normal Meningioma Normal Meningioma
1 -CH3 Lactate 1.33 18 50 1.44 1.9
2 -CH3 Alanine 1.45 11 65 0.8 2.15
3 -CH3 Acetate 1.87 23 17 0.22 0.11
4 -CH3 NAA 2.02 250* 218 11.4* 9.7
4 -CH3 Creatine 3.0 60* 57 2.61* 2.5
-CH3 Choline 3.2 30* 38 0.34* 0.44
*shows major peaks with clinical significance.
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II. Quantification of fat and amino acid metabolites in normal brain autopsy (a) and 
meningioma brain autopsy perchloric acid extract(b) by in vivo H-1 MR spectroscopy 
peaks shown in Figure 3C
Chemical 
shifts(ppm)
Resonance 
Assignment 
Peak area 
(mm2)
Normal
Meningioma
Concen-
tration 
(mM)
Normal
Meningioma
1.0 32 -
1.2-1.4 16.2 4.2 4.5 1.3
2.02 NAA(-CH2) 256 178 11.3 9.8
2.2-2.6 Glu/Gln( C H 2) 35 41 2 2.1
2.7 Aspartate( C H 2) 66 63 2.3 2.3
3.0 PCr+Cr(=NCH3) 102 84 7.4 6.8
3.2 Choline [-N+(CH3)3] 76 116 6.6 8.5
3.4 Taurine (SCH2) 29 31 0.6 0.6
3.6 Myoinositol 41 38 5.3 5.2
*signifies peak assignments with clinical significance.
DISCUSSION
Interpretation of NMR and MRS peaks in tissues pose a problem specially to extract out 
the  metabolite  NMR information  from  in  vivo clinical  NMR spectroscopy  [1,2,3,4].  The 
chapter provides a possible explanation for different T1 and T2 times and degree of NMR 
visibility of metabolites ex vivo and in vivo in diseases.
Tissue processing  before  MR experiments  also  affects  the  measurement.  Inconsistent 
water suppression, voxel size, Guassian peaks, Rf coil transmission/reception also affects the 
in  vivo  measurement.  In  our  study,  selective  water  saturation  spin  echo  FT  method 
highlighted methyl and methylene groups in different metabolites such as NAA(ABX spin 
system), lactate/alanine, and methylene groups in choline and glutamine/glutamate as NMR 
resonance assignments.
Table 8. I. Quantification of lipid, amino acid metabolism in normal liver biopsy (a); 
and diffused liver injury (b) perchloric acid biopsy extracts by ex vivo NMR spectra 
shown in Figure 2D. The standard 18 mM creatine solution was used as reference to 
measure metabolite concentration
Chemical
shift 
metabolites Peak area
(mm2)
Diffused 
Liver 
Concentration
(mM)
Diffused 
Liver
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.4
12
1.
1 
: P
os
te
d 
29
 D
ec
 2
00
9
Metabolites by Proton Ex Vivo NMR, In Vivo MR Spectroscopy Peaks
(ppm) Normal injury Normal injury
2.65  alanine
(carnosine)
2.5 1.3* - -
3.2 PCr+glycerophosphoryl
Choline 
6 35* 7.2 61.3
3.4 Taurine 5 35* 5.75 23.0
3.9 PCr/Cr 3 34* 0.48 1.06
4.1 Lactate 4 11* - -
5.5 Urea 6 73* - -
*shows major peaks with clinical significance.
II. Quantification of metabolites in normal liver biopsy (a); and diffused liver injury (b) 
perchloric acid biopsy extracts by in vivo NMR spectra as shown in Figure 3D. The 
standard 18 mM creatine solution was used as reference to measure metabolite 
concentration
Chemical 
shifts
(ppm)
metabolite Peak 
area(mm2)
Normal
Diffused 
liver
injury
Concentratio
n
(mM)
Normal
Diffused 
liver 
injury
1.51 and 1.82 -CH2(Fatty acids) 110 98
2.1-2.32 C H 2(glutamate) 430 456 10.08 10.92
2.4-2.5 C H 2(glutamate) 186 240 8.6 8.52
2.81 C H 2(aspartate) 89 21 6.27 2.7
3.1 [N+(CH3)3]Choline 21 12 6.8 3.9
3.28 [-N+(CH3)3]Carnitine 32 30
3.48 [=N+(CH2)]Carnitine 16 12
3.63-3.77 - glyceropho
sphorylcholine
63 40 7.5 5.1
6.1-6.5 (-CH2)Ribose(ATP) 60 42
6.6-6.7 Tyrosine 50 41
6.9 Histidine 35 34
7.1-7.6 Tryptophan 113 88 17.3 12.0
*shows major peaks with clinical significance.
In our study, smaller molecules could be visualized by proton MRS method and ex vivo 
NMR  method  in  perchloric  acid  tissue  extracts.  However,  ex  vivo  NMR  data  could  be 
affected  by  tissue  processing  method,  in  particular,  macromolecules  were  poorly  NMR-
visible [9]. So, comparison of smaller metabolites as fingerprints of disease is highlighted in 
this study. Moreover, previously smaller metabolites in homogenates were measured without 
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any  loss  during  tissue  processing  at  temperature  controlled  condition  as  fingerprint 
metabolites for diseased tissue reported [12].
The NMR data comparison with tissue contents and clinical chemistry lab data appear as 
clinical metabolic-MR correlates in DMD, MI, MB and DLI diseases where T1 and T2 appear 
as  tissue  specific  and  characteristic.  The  biochemical  basis  of  comparable  data  may  be 
significant to speculate the metabolite–MR correlates in different diseases are discussed in 
following discussion.
From NMR spectroscopy standpoint,  many methods have been applied to  obtain H-1 
NMR spectra  of living cells by reducing large  water  signal  by H2O replacement  method, 
water  elimination  Fourier  Transform  method,  difference  of  T1  relaxation  times  between 
water and other molecules by use of correlation NMR methods [5, 12]. We used selective 
water saturation FT NMR method at 400 MHz. Spectra showed broad ill defined components 
from  macromolecules  in  the  tissues.  To  reduce  broad  components,  spin  echo  FT  high 
resolution spectra  were used in which small  molecules such as lactate could be detected. 
Spectral  broad  components  seem  to  be  due  to  fast  relaxing  proton  fraction  and 
macromolecule protons.
In vitro NMR studies in muscle biopsy sample from DMD used decreased water signal 
and minor macromolecule signals existing in muscles and reduced complexity, to analyze H-1 
NMR spectra  of  muscle  from DMD persons.  Elevated  ex vivo NMR peak  amplitudes  of 
lipids, alanine, taurine, and glutamate reflected muscle fibrosis. DMD tissue homogenates and 
serum  chemistry  further  confirmed  the  elevated  levels  of  phospholipids,  triglycerides  in 
homogenates and serum creatine kinase, SGPT indicating fatty infiltration.  Small molecules 
resonance lines as decreased and narrow resonance lines were partially saturated due to signal 
tails,  making signal  intensity necessary  for  quantification.  These lipid signals  seem to be 
originated from the mobile lipids or depot lipids in muscle and not from membrane lipids. In 
normal muscle, no membrane phospholipids could be observed and only depot lipids could be 
observed.  Mainly  they  were  phospholipids  and  fatty  acids.  The  high  resolution  spectra 
showed also other important metabolites such as phosphocreatine, urea, glutamine, glutamate 
and alanine. Previously, triglycerol resonance and histidine of anaserine have been reported 
along with elevated lactate and large peaks of choline, creatine in muscle ischemia [18] (8). In 
DMD,  muscle  showed  the  elevated  lipids  and  carnosine  content.  In  vivo  H-1  MR 
spectroscopy provided the identification of resonances from intracellular metabolites. In vivo 
MRS peak pattern also suggested fatty infiltration. Earlier depot lipids have been reported in 
muscle  with  elevated  lactate,  choline,  creatine  in  muscle  ischemia  [19].  Muscle 
unsaturated/saturated fat ratio and fatty acyl resonances were characterized by peak height 
ratios of polyunsaturated to carbonyl carbons [12]. Composition and resolution of fatty acyl 
chains  and  with  quantification  of  unsaturated-saturated  fat  ratio  in  muscle  was  reported 
[21](9).  The fat metabolism in muscle appears  to be altered to synthesize unsaturated fat. 
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Quantification  of  metabolites  have  been  approached  by  the  ratio  of  peak  heights  of 
polyunsaturated to carbonyl carbons which showed decreased levels of unsaturated fatty acids 
in various diseases of muscles as cystic fibrosis, lipoprotein lipase deficiency [20, 22]. These 
recent studies suggested the same clue for in vivo metabolic muscular dystrophy quantitative 
assessment by NMR if treatment could be started early and diagnosed. It can be concluded 
that muscles from normal persons show peaks from phosphocreatine/creatine,  choline and 
carnosine  as well as fatty acyl chains while DMD affected muscle demonstrated multiple 
resonances from various fatty acids.
The present study also suggests similar clues for phosphocreatine/creatine and fatty acyl 
protons in normal and multiple fatty acyl proton NMR resonances. These suggest possible 
following metabolic reaction catalyzed by creatine kinase:
Phosphocreatine + H+ + ADP ATP + creatine.
It also supports the elevated levels of serum creatine kinase, reduced phosphocreatine as 
a result of energy depletion and active oxidative state in DMD muscle. Associated elevation 
of  SGPT  in  serum  and  reduced  phospholipids  in  DMD  muscle  tissue  suggested  the 
accumulation of  alanine  and lactate  due  to  muscle  fibrosis  and  dystrophy.  Earlier  report 
suggested similar reduced Pi signal and increased fat (-CH2) signal in dystrophic process 
(replacement of muscle fibers with fibrous tissue) as reduced phosphocreatine/ATP ratio [13]. 
Phospholipids generate fatty acids by  oxidation (acetyl CoA formation) for mitochondrial 
ATP generation during relaxation-contraction in muscle. The protons of choline appear to 
reflect muscle growth status. Earlier different ratio of mono/di unsaturated lipids suggested 
metastasis [23]. Similarly DMD muscle atrophy and fibrosis can be ascribed as depletion of 
phosphocreatine, elevated phosphodieaters, fatty acids and fatty infiltration. Muscle fibrosis 
and  energy  depletion  in  Duchene  Muscular  Dystrophy  muscle  tissue  was  common 
manifestation reflected as elevated ex vivo NMR peak amplitudes of lipids, alanine, taurine, 
and glutamate. The elevated presence of glutamine/glutamate can be speculated due to its 
rapid  generation  from  NMR  visible  - ketoglutarate  by  SGPT  and  active 
glutamine/glutamate  synthase  for  energy  supply  as  recently  evidenced  [14].  Creatine  is 
product  of  amino  acid  breakdown  and  generates  phosphocreatine.  Taurine  facilitates  the 
synaptic connections in ion movement where glutamate is an excitatory amino acid in muscle.
In normal heart spectra, the NMR line widths showed good resolution. In vitro NMR data 
of human diseased heart autopsy is less known. The spectra showed resonances of  α,β,γ -
(CH2)n- and terminal methyl protons visible in myocardial infarct heart autopsy perchloric 
extracts  indicated  energy  metabolic  depletion and  fatty  infiltration.  Other  elevated  major 
metabolites were lactate, Cr+PCr and diminished taurine with unaletered fatty acids or lipids. 
In normal heart, taurine was present in large quantities in cardiac tissue and carnitine was not 
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as abundant because myocardium has fatty acyl carnitine.  Considering number of protons 
contributing  to  each  resonance,  relative  intensities  of  taurine  and  carnitine  peaks  were 
consistent with previously reported values [24]. Myocardial glycosides were seen in spectra 
and they were thought to be distributed in several pools without different metabolic turnover 
rates  as well as biochemical characteristics.  In spectra,  several  peaks were observed from 
metabolically  mobilizable  myocardial  glycerides  and  free  fatty  acids  but  not  from  rapid 
turnover glycerides. Moreover, glycerides were not NMR visible in heart extracts. The reason 
may  be  that  multiple  glyceride  pools  based  upon  metabolic  turnover,  possess  different 
physical characteristics and large accumulated amount in heart were not visible. Although, 
biochemical assays showed elevated serum triglycerides and suggested possibility of slow 
and high rate turnover of myocardial triglycerides. Distinct phospholipids and triglycerides 
after fasting were identified and quantitated by NMR spectra but fatty acid chains remained 
unchanged [25].  It  showed two myotriglycerides  pools:  slow rate  turnover  and high rate 
turnover.  In present study,  no accumulation of lactate or  lesser  extent was observed with 
unaltered taurine, carnitine in myocardial infarction heart NMR[26]. It may be attributed to 
the  fact  that  lactate  easily  traverses  across  cell  membranes  or  would  have  washed away 
during perchloric acid extraction. Thus H-1 NMR spectra of cardiac muscle can be used for 
the diagnosis of cardiac disorders.
The effect of myocardial lipid deposition on the signal peaks from alanine, glutamate and 
aspartate can be attributed to the fact that alanine is a product of pyruvate after glycolysis and 
diseased  heart  tissue  reduces  its  ability  to  oxidise  lactate  when  returned  to  oxidative 
metabolism. Increased succinate can be attributed to inoperative citrate to ketoglutarate in 
tricarboxylic  acid  cycle  [27].  The  α-Ketoglutarate  production  comes  from  alanine 
transamination (alanine transferase) which is the primary source of succinate. Thus alanine 
and  ketoglutarate  maintain  a  balance.  The  α-Ketoglutarate  generates  less  glutamate  by 
glutamate  dehydrogenase  reaction,  showing  glutamate  fall  observed  in  spectra.  Thus 
ketoglutarate  rapidly  gets  converted  to  succinate  and  less  to  glutamate.  Simultaneously, 
oxaloacetate  gets  converted  to  malate  by  increased  NADH/NAD+ ratio  leaving  low 
oxaloacetate  content.  So  malate,  alanine  and  succinate  metabolites  showed  a  rise  in 
myocardial  muscle  due  to  continuous  consumption  of  glutamate  and  aspartate  in  alanine 
aminotransferase  reactions  (glutamate  uptake  and  alanine  release)  and  aspartate 
aminotransferase reactions (aspartate oxaloacetate and malate). It is to be noted that alanine 
and succinate accumulation in energy depleted heart muscle was accompanied by release of 
lactate. Lactate and alanine are known to pass through the heart cell membranes radily while 
succinate kinetics is not known. Succinate appearance in extracellular space may be due to 
membrane damage or its enhanced synthesis. The ability of alanine and succinate to diffuse 
into myocardium indicates value of these compounds as markers of cardiac oxidative defect. 
So, release of metbolites seems to be lactate > alanine > succinate > creatine. However, MI 
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heart homogenates and sera chemistry also indicated elevated triglycerides, cholesterol and 
lactate in homogenates and serum triglycerides, creatine kinase-MB as previously reported 
[28].
Proton  localized  in  vivo  MR  spectroscopy  showed  elevated  cholesterol,  alanine, 
glutamate, aspartate peaks and suggested more energy demand as metabolite characteristic of 
heart and suggested the potential of H-1 spectroscopy for providing insights into biochemical 
metabolic status of heart wall. In cardiac muscle metabolic spectroscopy, shimming and water 
referencing were done by surface coil position under chest.  The heart  motion effects and 
shape of  water  peak problems were  reduced by shimming.  Homogenous water  peak was 
obtained.  Resonances  from  PCr/Cr  and  taurine  were  characteristically  unchanged  but 
additional saturated fatty acid resonances were observed in the aliphatic region 1.6 – 2.55 
ppm  and  5.7  –  5.95  ppm  due  to  –CH=CH-  protons  which  is  related  with  decreased 
unsaturated/saturated fatty acid ratio in the tissue [14, 29]. Our data corroborates with these 
metabolites except lactate [29]. Other reports on  31P-MR spectroscopy using rotating frame 
technique, ISIS also indicates additional saturated fatty acids and lactate levels in myocardial 
infarction and phospholipids characterization [30, 31]. In present study, we did not observe 
lactate  peak.  Elevated  creatine  phosphokinase-MB  suggested  a  scientific  explanation  to 
interpret the reason of disease and perhaps may be helpful in therapeutic monitoring. Higher 
glutamate appearance in MR spectra was also supported because of its protective action [32]. 
Moreover,  myocardial  infarction  and  lipid  metabolites  have  been  reported  where  distinct 
metabolites  ratio  and quantification was attempted [33].  It  may be concluded that  energy 
metabolic depletion and fatty infiltration in myocardial infarcted heart autopsy were possibly 
manifested as elevated  ex vivo NMR peaks of elevated lactate, diminished taurine, Cr+PCr 
and unaltered fatty acids or lipids in MI heart homogenates. In vivo MRS exhibited elevated 
cholesterol, alanine, glutamate, aspartate due to more energy requirement in tissue.
The ex vivo NMR spectroscopy of meningioma brain autopsy samples exhibited several 
metabolites by chemical shift peak positions for lactate, glutamine, glutamate and choline. 
Applicability  of  H-1  NMR  for  characterization  of  distinct  metabolites  in  normal  and 
meningioma  tissue  has  been  established  based  on  the  localized  differences  at  different 
sections of brain sites. Our study shows that lactate and other metabolites in brain autopsy 
samples of meningioma brain have elevated levels as compared to normal brain spectra. In 
present  study,  meningioma  brain  spectra  showed  poor  resonance  peaks  of  low  N-
acetylaspartate,  glutamate,  glutamine,  pyruvate,  acetoacetate,  phosphocreatine/creatine  but 
showed major resonances from lactate, choline and alanine with aspartate and taurine. The 
absence of glutamine/glutamate in meningioma may be attributed to lack of enzyme system 
(glutamate synthase/aspartate  transaminase)  perhaps leading to  taurine  accumulation. Low 
phosphocreatine  in meningioma than the normal brain tissue could be attributed to lower 
supply of glycine and ornithine to remove ammonia which leads to hyperammonemia and 
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decreased glutamate available [34]. The meningioma spectra did not show enhanced signals 
of  choline  containing  compounds.  Moreover,  the  lipids,  lactate  and  glucose  contents  in 
meningioma tumors could not be characterized further.
The H-1 localized spectroscopic observations suggested NAA, creatine and choline show 
up as distinct assignments by both NMR and localized MR spectroscopy. Neuronal changes 
in meningioma brain appear associated with elevated ex vivo NMR peaks of lactate, choline 
and  alanine  but  depleted  peaks  of  NAA,  glutamate/glutamine,  pyruvate,  acetoacetate. 
Previous study reported  in vivo volume localized 1H spectroscopy suggested intensity of N-
acetylaspartate, and creatine in meningioma less than normal tissue intensities but elevated 
choline and lactate resonance similar to our observations [34-37]). Water suppressed proton 
spectroscopy still is a new method for analyzing fat content of brain tissue because of good 
resolution of various protons in fatty acyl chains and area analysis under peak to visualize 
unsaturated/saturated fat ratio in the tissue. Better picture of disease was reported by energy 
metabolites ATP, ADP and AMP along with inorganic Pi and sugar phosphates by 13C NMR 
and 31P NMR indicating metabolites mainly participate in energy regulation [38]. Rise of Pi 
stimulates the glycolysis and lactate production,  causing acidosis.  Both the PCr and ATP 
depleted and Pi accumulates while ADP is lost via conversion to AMP, inosine phosphate 
(IMP), adenine and ultimately hypoxanthine and urates. Immobilized ion pump Na+/K+ causes 
irreversible membrane structural damage accompanied by elevated glutamate which is NMR 
visible. The above sequence of metabolite generation occurs in brain during diseased state. 
Brain phosphomonoeasters as phosphotydylethanolamine, plasmalogens in white matter and 
myelin,  are  mainly  synthesized  by  ethanolamine  kinase  and  desaturase  during 
myelinogenesis.  Thus  PME/ATP  and  PME/PDE  ratio  seem  useful  31P  NMR  tools. 
Glycerophosphocholine and glyceroethannolamine are phosphodiesters and are synthesized 
during  myelination by ethanolamine phosphotransferase.  NAA provides  anion  balance  in 
brain, acetyl group transport, contribution of acetyl groups for fatty acid synthesis, regulation 
of myelin synthesis, acetyl CoA and biogenic amine generation in brain (NAA-glutamate). 
Taurine facitates further brain neurone synaptic connection in developing neuronal tissue and 
further controls ion movement, magnesium homeostasis and maintains structural integrity of 
brain cell membranes because of its ability to modulate calcium homeostasis. Glutamate is 
excitatory amino acid neurotransmitter and plays a part in trnasamination. In meningioma, N-
acetylaspartate, creatine decreased while choline and taurine accumulated. Neuronal changes 
in meningioma brain were associated with elevated ex vivo NMR peaks of lactate and alanine 
but depleted peaks of pyruvate,  acetoacetate,  choline.  In vivo MRS exhibited elevated N-
acetyl aspartate (NAA) and choline peaks.
In  water  saturated  spin-echo FT,  in  vitro  NMR spectroscopy  of  normal  liver  biopsy 
evidenced  histidine,  tryptophan,  choline,  glutamate/glutamine.  Water  and macromolecules 
signals were sufficiently suppressed. Spin echo based H-1 NMR spectra were largely reported 
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on alternatively adding and substracting modulated spectra obtained from CPMG and Hann 
spin echo experiments [39]. Still reports are not conclusive on liver metabolic information 
using in vitro NMR methods. Consequently, human liver in vivo H-1 NMR is not currently 
acceptable in clinical set up. In our study, normal liver NMR spectra showed fatty acyl –CH2- 
protons, glutamate/glutamine, choline, carnitine, glycerophosphoryl choline, aromatic amino 
acids. Diffused liver injury liver biopsy demonstrated a depletion of unsaturated fatty acid, 
glutamate/glutamine,  lactate  and  dynamic  lipids.  However,  mobile  lipids  could  not  be 
discriminated even by exploiting metabolite T2 differences.  For other metabolites such as 
glycerophosphoryl choline and depleted glutamate/fatty acid pool peaks were NMR visible. 
These  NMR peaks  were  associated  with  elevated  levels  of  ALT and  AST transaminase, 
cholesterol, bilirubin and alkaline phosphatase in serum. This may be explained on the basis 
of  parenchymal  cells  capacity  decreased  for  clearing  glycerophosphoryl  compounds  and 
active deposits  of  fats  which is generally  one of the precipitating factors  of  “fatty liver” 
condition  supported  by  histology  findings  [40].  As  a  result  of  this  liver  condition,  liver 
intracellular  energy  flux  presumably  diverts  towards  more  ATP  generation  which  needs 
acetyl  CoA,  a  regulatory  central  metabolite.  It  can be explained originated  either  from  β 
oxidation of fatty acid or originated from glutamate by transamination. Eventually, it leads to 
depleted glutamate and fatty acid pools and cholesterol, serum glutamate transaminase and 
phospholipids. In general,  in vitro H-1 NMR spectral  peaks allowed identification of well 
defined intracellular metabolites characteristic of normal liver. Although pathophysiological 
mechanisms  of  diffused  liver  injury  are  poorly  defined,  resonance  peak  metabolite 
quantification by spectroscopy provides noninvasive insight of metabolite identification and 
possible biochemical characterization. Composition of lipids and fatty acyl chain chemicals 
were resolved and quantified as unsaturated-saturated fat ratio in liver to infer the cause of 
diffused liver injury [41]. The fatty metabolites in liver associated with liver injury have been 
attributed to higher concentration of cholesterol, triglyceride and free fatty acids, glutamate, 
amino acids and phospholipids in circulation, which leads to accumulation of saturated lipids, 
which may be assessed by H-1 MR spectroscopy. Earlier quantification of metabolites has 
been approached by peak height ratio of polyunsaturated fatty acid and carbonyl proton peaks 
which  were  decreased  in  various  diseases  such  as  alcohol  liver  disease,  hepatitis  and 
transplantation graft viability assessment [42]. Liver has parenchymal and nonparenchymal 
cells  responsible  for  intracellular  metabolism.  Parenchymal  cells  regulate  glycolysis, 
tricrboxylic acid cycle, and energy storage in the form of fatty acids [43]. Mainly pyruvate 
oxidation, lactate accumulation and higher consumption of glutamate/glutamine seem to be 
evident in diffused liver injury[44]. In mitochondria, ATP production by NADH oxidation 
and oxidative phosphorylation is needed for gluconeogenesis, lipogenesis[45]. In liver injury, 
ATP supply becomes paralyzed leading to depletion of phosphocreatine and alkalosis. Fatty 
infiltration and lactate accumulation and saturated lipids in diffused liver injury (DLI) liver 
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tissue  were  manifested  as  elevated  ex  vivo NMR  lactate,  lipid  peaks  [46,  47].  It  was 
concluded that H-1 NMR spectroscopy can identify lactate,  glutamate/glutamine,  glucose, 
creatine, ATP, aspartate, fatty acids and glucose. In vivo MRS showed depleted amino acids 
due to fatty infiltration. Thus both biochemical and MR findings show lactate accumulation, 
depleted glutamate, unsaturated fatty acids, glucose and phosphocreatine.
Limitations of present study: We could not get clue for mechanism of disease, turn over 
or biosynthesis because of NMR analysis only visualized the elevated metabolites in tissue. 
Combining NMR metabolite data with metabolites in tissue homogenate contents and sera 
appears  to  speculate  many  systematic  events  and  new  biochemical  definition  of  fatty 
infiltration, neuronal dysfunction and energy depletion. In near future, continuing efforts of 
high resolution NMR combined with localized diffusion, perfusion, functional MR imaging 
methods may be ideal for biochemical characterization of diseases. In future, better computer 
peak analysis and MRS with MRI techniques presumably will provide on-line MRS peaks 
and localized metabolite composition with more accuracy.
Limitations of present study: We could not get clue for mechanism of disease, turn over 
or biosynthesis because of NMR analysis only visualized the elevated metabolites in tissue. 
Combining NMR metabolite data with metabolites in tissue homogenate contents and sera 
appears  to  speculate  many  systematic  events  and  new  biochemical  definition  of  fatty 
infiltration, neuronal dysfunction and energy depletion. In near future, continuing efforts of 
high resolution NMR combined with localized diffusion, perfusion, functional MR imaging 
methods may be ideal for biochemical characterization of diseases. In future, better computer 
peak analysis and MRS with MRI techniques presumably will provide on-line MRS peaks 
and localized metabolite composition with more accuracy.
CONCLUSION
Ex vivo and in vivo NMR spectral peak observations in different diseases can support the 
reliability  of  clinical  applications  using  in  vivo localized H-1  MR spectroscopy  peaks to 
determine the  biochemical  cause of  disease.  In  future,  better  computer  peak analysis  and 
MRS techniques presumably will provide on-line MRS peaks with more accuracy. However, 
peak identification, peak analysis, quantitation of metabolites from ex vivo NMR and in vivo 
MRS data is presently, remains a big challenge.
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APPENDIX I:
STRATEGY OF METABOLITE QUANTITATION BY MR SPECTROSCOPY
For in vitro and in vivo NMR spectroscopy, there is imperative need of reliable peak 
processing to measure metabolites due to broad and inhomogeneous overlapped peak shapes. 
Many methods based upon NMR signal time domain fitting to specific model functions are 
available like LPSVD, HSVD, MEM using Lorentzian or Gaussian line shapes. However, 
deviated  line  shapes  of  spectra  cannot  be  corrected.  We used the  following methods for 
metabolites.
1.  For  N-acetyl  aspartate,  creatine/phosphocreatine  and  choline:  Using  fully  relaxed 
water  signals  as an internal  standard,  the average metabolite  concentrations in volume of 
interest (VOI) was calculated as: 
Concn of NAA = Concn of water (NAA peak area x 2)/ (water peak area x 3)
Concn of PCr/Cr = Concn of water (PCr.Cr peak area x 2)/(water peak area x 3)
Concn of Choline = Concn of water (Cho peak area x 2)/(water peak area x 9)
Peak area denoted signal peak correlated for both T1 and T2 relaxation. Water signal is 
related with peak area as:
Area under peak = S (1- e-TR/T1), where S is area under peak to a given TR repetition time 
and S is signal at TR = ∞
Area under peak = So (e-TE/T2) where So is area under peak to a given TE echo time and So 
is signal at TE = 0 as described earlier [1].
Internal water was used as standard to calculate metabolites by proton unsuppressed MR 
spectra. Other less visible metabolites can be compared with water peak area at tissue water 
concentration 55 M. 
2.  For  Phospholipids,  inorganic  phosphorus  and  cholesterol:  By  comparing  digital 
integration of peaks with that of internal standard, concn can be measured:
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Wu = Ws x Sf ( Ns. Mu. Iu)/(Nu. Ms. Ts), where Wu and Ws are weights of unknown and 
standard solutions, Nu and Ns are active nuclei number, Mu and Ms are molecular weights, Iu 
and Is are signal integrals of unknown and standard solutions, Sf is saturation factor. The 
molecular  weights  of  standards  were:  cholesterol(380),  phospholipids(750),  Pi(95)  as 
described earlier [2].
3.  For  glutamate,  N-acetyl  aspartate,  glutamine,  aspartate:  Addition  reference  signal 
resonance with same lineshape was introduced which depends upon spin-spin relaxation time 
(T2). The signal represents FID having pure Lorentzian lines. 
S(t) = Vj exp[i . t ]exp (-t/T2j)  where 1/T2j = [1/ T2j – 1/T2r + 1/T] where T2j is spin-spin 
relaxation, r is spatial dependency,  is frequency of jth line.
The concentration IEK = (Ak/Au)(Cu/Ck)(3/Nk) where IEK is  effective signal intensity of 
unknown compound, Ak and Au are amplitudes of known and unknown compounds, Ck and 
Cu are concentrations. Nk is number of protons contributing of known components [3].
1. Christiansen  P,  Henriksen  O,  Stubgaard  M,  Gid  P,  Larsson  HBW.  In  vivo 
quantitation ofbrain metabolites by H1 NMRS using water as an internal standards. 
Magnetic Resonance Imaging.1993,11:107-118.
2. Mariner  DM.  High  resolution  NMR  spectroscopy  of  cerebral  white  matter  in 
multiple sclerosis. Magnetic Resonance in Medicine 1990,13:343-357.
3. Van  Dijk  JE,  Mehlkopf  AF,  Ormondt  DV,  Bovee  WMMJ.  Determination  of 
concentrations  by  time  domain  fitting  of  proton  NMR  echo  signals  using  prior 
knowledge. Magnetic Resonance in Medicine 1992,27:76-96.
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